Cited 0 times in
Phase II study of sitravatinib in combination with tislelizumab in patients with advanced biliary tract cancer who have failed to at least 1 prior systemic treatment: Trial in progress
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강버들 | - |
dc.contributor.author | 이충근 | - |
dc.date.accessioned | 2023-06-02T01:05:52Z | - |
dc.date.available | 2023-06-02T01:05:52Z | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194651 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | American Society of Clinical Oncology | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Phase II study of sitravatinib in combination with tislelizumab in patients with advanced biliary tract cancer who have failed to at least 1 prior systemic treatment: Trial in progress | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Do-Youn Oh | - |
dc.contributor.googleauthor | Jin Won Kim | - |
dc.contributor.googleauthor | Hongjae Chon | - |
dc.contributor.googleauthor | Choong-kun Lee | - |
dc.contributor.googleauthor | Ji-Won Kim | - |
dc.contributor.googleauthor | Beodeul Kang | - |
dc.contributor.googleauthor | Hye Jin Choi | - |
dc.contributor.googleauthor | Se Jun Park | - |
dc.contributor.googleauthor | Jeesun Yoon | - |
dc.contributor.googleauthor | Myung Ah Lee | - |
dc.identifier.doi | 10.1200/JCO.2022.40.4_suppl.TPS490 | - |
dc.contributor.localId | A00029 | - |
dc.contributor.localId | A03259 | - |
dc.relation.journalcode | J01331 | - |
dc.identifier.eissn | 1527-7755 | - |
dc.identifier.url | https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.TPS490 | - |
dc.contributor.alternativeName | Kang, Beo Deul | - |
dc.contributor.affiliatedAuthor | 강버들 | - |
dc.contributor.affiliatedAuthor | 이충근 | - |
dc.citation.volume | 40 | - |
dc.citation.number | 4 suppl | - |
dc.citation.startPage | TPS490 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 suppl) : TPS490, 2022-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.